Effects of Neuromuscular Electrical Stimulation on Glucose Variability in

Status Completed

Clinical Trial Summary

In patients with type 2 diabetes mellitus (T2DM) chronic hyperglycemia is the main cause of complications, promoting several micro and macrovascular damages. In order to understand other mechanisms that could have an impact on the development of these diabetic complications, the assessment of glycemic variability have been widely used. Glucose control can be achieved with multiple interventions, including exercise training. Some individuals, however, especially those with autonomic neuropathy, can have exercise intolerance. In this context, physical therapy proposes neuromuscular electrical stimulation (NMES) as a therapeutic that has been applied in research and clinical practice as an alternative to the training of patients who cannot perform conventional exercise. In patients with T2DM, NMES was shown to improve glycemic control and insulin sensitivity, but quality of these trials is poor. In addition, the effects of NMES on glycemic variability of T2DM patients have not yet been reported. The aim of this study is to evaluate the effects of NMES on glucose levels and glucose variability in patients with T2DM.

Clinical Trial Description

Patients with T2DM will be recruited from outpatient clinic of the Hospital de Clinicas de Porto Alegre. Patients will be randomized to NMES session, with maximal intensity tolerance by to induce visible contractions or to NMES-placebo, with minimal intensity to provide a sensory stimulus, but insufficient to elicit a tetanic muscular contraction. Subjects will attend to research facility four times. On the first visit clinical, physical examination and autonomic evaluation (Ewing test) will be performed and a blood sample will be collected. On the second visit CGMS will be placed for glycemic variability evaluation. On the third visit NMES or NMES-placebo will be performed in a randomized way. On the fourth visit the CGMS will be removed. Blood pressure and heart rate will be evaluated during the protocol each 5 minutes and oxygenation tissue will be evaluated before, during and immediately after the protocol, through NIRS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03256747
Study type	Interventional
Source	Hospital de Clinicas de Porto Alegre
Contact
Status	Completed
Phase	N/A
Start date	September 15, 2017
Completion date	May 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04082091` - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Active, not recruiting	`NCT02248311` - "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population	N/A
Completed	`NCT02653300` - A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)	Phase 2
Completed	`NCT03655535` - Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes	Phase 2
Withdrawn	`NCT03675074` - Neujia Anastomosis for Treatment of Obesity and Type II Diabetes	N/A
Completed	`NCT05343767` - Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus	N/A
Withdrawn	`NCT03190798` - Effects of Canagliflozin on Intravascular Volume and Hemodynamics	Phase 4
Withdrawn	`NCT03437330` - Empagliflozin Effect on Glucose Toxicity	Phase 4
Withdrawn	`NCT03008395` - Empowerment, Motivation and Medical Adherence (EMMA).	N/A
Not yet recruiting	`NCT05539066` - AI Health Assistant and Type 2 Diabetes	N/A
Completed	`NCT03682445` - Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus	N/A
Not yet recruiting	`NCT03239119` - The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus	Phase 3
Completed	`NCT03259789` - Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects	Phase 3
Recruiting	`NCT03506230` - Financial Incentives for Low Socioeconomic Diabetic Patients	N/A
Completed	`NCT03072407` - MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM	Phase 1
Completed	`NCT05668442` - Feasibility of an Online Exercise Community Among Individuals With Type 2 Diabetes
Completed	`NCT02956044` - Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin	Phase 1
Completed	`NCT02964572` - Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes	N/A
Completed	`NCT02628392` - A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)	N/A
Completed	`NCT03104738` - Basal Insulin Strategies Before Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Neuromuscular Electrical Stimulation on Glucose Variability in Patients With Type 2 Diabetes

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms